CD8A and neoplasm: Second, ANG-2 renders the endothelium more sensitive to immune cell binding and infiltration towards the parenchyma/tumor (39, 40).Third, combined anti-VEGF and ANG-2 inhibition enhanced anti-tumor activity of CD8+ cytotoxic T-cells and showed complementary effects with immunotherapy (41).